Search research articles
Contact Us
Filters
Showing results (31-40 of 40) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 40 results.
Biochemical Pharmacology
|
June 12, 2019
The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics
Patrik Prša, Betül Karademir, Gökhan Biçim, et al.
Heliyon
|
March 10, 2023
Compounds originating from the edible mushroom <i>Auricularia auricula-judae</i> inhibit tropomyosin receptor kinase B activity
Orr Shahar, Idan Pereman, Hazem Khamisie, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 30, 2023
TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer
Jonathan Zorea, Yair Motro, Roei D Mazor, et al.
Journal of Cancer Research and Clinical Oncology
|
May 9, 2016
Exploring an herbal "wonder cure" for cancer: a multidisciplinary approach
Eran Ben-Arye, Jamal Mahajna, Radi Aly, et al.
BMC Cancer
|
September 19, 2012
Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
Afsar Ali Mian, Anna Metodieva, Susanne Badura, et al.
Molecular Biology Reports
|
April 4, 2008
Marasmius oreades substances block NF-kappaB activity through interference with IKK activation pathway
Roumyana D Petrova, Jamal Mahajna, Solomon P Wasser, et al.
Nutrients
|
November 25, 2023
Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents
Rosita Gabbianelli, Ehud Shahar, Gaia de Simone, et al.
Annals of Hematology
|
June 10, 2021
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1<sup>T315I</sup> and BCR-ABL1<sup>T315I-E255K</sup>
Afsar Ali Mian, Isabella Haberbosch, Hazem Khamaisie, et al.
Biomolecules
|
November 27, 2024
Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer
Junbiao Wang, Daniela Beghelli, Augusto Amici, et al.
Seminars in Cancer Biology
|
April 21, 2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Mark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 40) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 40 results.
Biochemical Pharmacology
|
June 12, 2019
The potential use of natural products to negate hepatic, renal and neuronal toxicity induced by cancer therapeutics
Patrik Prša, Betül Karademir, Gökhan Biçim, et al.
Heliyon
|
March 10, 2023
Compounds originating from the edible mushroom <i>Auricularia auricula-judae</i> inhibit tropomyosin receptor kinase B activity
Orr Shahar, Idan Pereman, Hazem Khamisie, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
April 30, 2023
TRAF3 suppression encourages B cell recruitment and prolongs survival of microbiome-intact mice with ovarian cancer
Jonathan Zorea, Yair Motro, Roei D Mazor, et al.
Journal of Cancer Research and Clinical Oncology
|
May 9, 2016
Exploring an herbal "wonder cure" for cancer: a multidisciplinary approach
Eran Ben-Arye, Jamal Mahajna, Radi Aly, et al.
BMC Cancer
|
September 19, 2012
Allosteric inhibition enhances the efficacy of ABL kinase inhibitors to target unmutated BCR-ABL and BCR-ABL-T315I
Afsar Ali Mian, Anna Metodieva, Susanne Badura, et al.
Molecular Biology Reports
|
April 4, 2008
Marasmius oreades substances block NF-kappaB activity through interference with IKK activation pathway
Roumyana D Petrova, Jamal Mahajna, Solomon P Wasser, et al.
Nutrients
|
November 25, 2023
Plant-Derived Epi-Nutraceuticals as Potential Broad-Spectrum Anti-Viral Agents
Rosita Gabbianelli, Ehud Shahar, Gaia de Simone, et al.
Annals of Hematology
|
June 10, 2021
Crizotinib acts as ABL1 inhibitor combining ATP-binding with allosteric inhibition and is active against native BCR-ABL1 and its resistance and compound mutants BCR-ABL1<sup>T315I</sup> and BCR-ABL1<sup>T315I-E255K</sup>
Afsar Ali Mian, Isabella Haberbosch, Hazem Khamaisie, et al.
Biomolecules
|
November 27, 2024
Chaga Mushroom Triterpenoids Inhibit Dihydrofolate Reductase and Act Synergistically with Conventional Therapies in Breast Cancer
Junbiao Wang, Daniela Beghelli, Augusto Amici, et al.
Seminars in Cancer Biology
|
April 21, 2015
Sustained proliferation in cancer: Mechanisms and novel therapeutic targets
Mark A Feitelson, Alla Arzumanyan, Rob J Kulathinal, et al.
Page
of 4